VitaNova Life Sciences (VNOV) Change in Account Payables (2017 - 2026)

VitaNova Life Sciences (VNOV) posted Change in Account Payables of -$59472.0 for Q1 2026, down 891.2% on a QoQ basis from -$6000.0 in Q4 2017.

VitaNova Life Sciences (VNOV) Change in Account Payables (2017 - 2026) Analysis & Trends

VitaNova Life Sciences' Change in Account Payables history runs 2 years deep, the most recent figure standing at -$59472.0 for Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Account Payables (Qtr)
1	Mckesson	105.15 Bn	101.18 Bn	4.04 Bn	-574.00 Mn
2	Cencora	60.58 Bn	58.40 Bn	3.59 Bn	-3.50 Bn
3	Cardinal Health	53.81 Bn	49.87 Bn	2.50 Bn	-1.16 Bn
4	Henry Schein	9.71 Bn	9.57 Bn	1.07 Bn	-
5	Akso Health	3.28 Bn	3.28 Bn	-	-
6	111	651.73 Mn	572.63 Mn	23.58 Mn	-
7	Accendra Health	248.02 Mn	-88.86 Mn	278.03 Mn	8.78 Mn
8	Edap Tms	230.14 Mn	215.14 Mn	8.15 Mn	918,000.00
9	VitaNova Life Sciences	11.51 Mn	11.01 Mn	316,343.00	-59,472.00
10	Cosmos Health	9.57 Mn	7.41 Mn	1.38 Mn	-

Download Data